Migeon e t a 1 (1968) d e s c r i b e d a n e n t i t y of a d r e n a l unresponsiven e s s t o ACTH c h a r a c t e r i z e d by hypoglycemia,hyperpigmentation normal t o l e r a n c e t o s a l t d e p r i v a t i o n and no e l e v a t i o n o f plasma cort i s o l with ACTM. The p o s s i b i l i t y of X-linked and autosomal forms s u g g e s t s h e t e r o g e n e i t y i n t h i s r a r e c o n d i t i o n . Tlio a f f e c t e d brothe r s , o f f s p r i n g of f l r s t -c o u s i n p a r e n t s a r e p r e s e n t e d . The f i r s t c a s e d i e d a t t h e age of t h r e e y e a r s of "unknown cause" with a h i s t o r y o f i n t e r m i t t e n t hypoglycemia p r e c i p~t a t e d by t h e s t r c s s o f i n f e c t i o n s . Post-mortem examination r e v e a l e d marked hyperpigmentat i o n , c e r e b r a l edema, s m a l l f o c i of c a l c i f i c a t i o n s s c a t t e r e d i n t h e a r t e r i o l a r wall. Thc a d r e n a l s were h y p o p l a s t i c showing degene r a t i o n of t h e zona f a s c i c u l a t a and r c t i c u l a r i s , with p r e s e r v a t i o n of t h e zona glomerulosa. The second son s t a r t e d with s i m i l a r s i g n s and symptoms a t t h e age of two y e a r s and a l s o showed hyperpigment a t i o n when he was admitted t o t h e P e d i a t r~c S e r v i c e o f t h e Univers i t y o f B r a s i l i a , s i x months l a t e r . Laboratory i n v e s t i g a t i o n r evealed 28m& g l u c o s e , 136mEq/l sodium, 4 , l m~q / l potassium,calcium, phosphorus, u r i c a c i d , a l k a l i n e phosphatase, c o l e s t e r o l , t r i g l yc e r i d e s were within normal range. h d o c r i n e t e s t i n g showed normal IIGM, PRL, T3, T4, TSlI r e s p o n s e s . The c o r t i s o l l e v e l s were undetecta b l e even a f t e r s i x hours I V ACTH a d m i n i s t r a t i o n . The p a t i e n t was p u t i n a r e g u l a r d i e t with prednisonc 2,5mg t w l c e d a i l y and is q u i t e w e l l on t h i s regimen. Approximately 10-20% o f the Prolactinomas a r e recognized before age 20. However, t h e r e a r e few r e p o r t s on t h e i r medium and l o n g term follow-up. T h i r t e e n p a t i e n t s ( 8 % . 9 6 ) aged 14.2 -20 y r . (X 16.5 y r ) w i t h p r o l a c t~n o m a were followed f o r 9 m-12 y r . Headaches, impairment of p u b e r t a l development, galactorrhea and v i s u a l f i e l d defects were the most comnon c l i n i c a l findings. The responses o f LH and FSH t o LH-RH among p a t i e n t s v a r i e d from normal, exaggerated o r absent. THe TRH (TSH) t e s t was normal i n 819 cases and i n 1 . $ a primary concomitant hypothyro/dism was reported.
Serum PRL was e l e v a t e d i n a l l p a I l e n t s ranging 77-1150 nglml ( X 3 7 8~2 8 5 ) . PRL r e sponse a f t e r TRH was inadequate (X A MAX:25%). R a d i o l o g i c a l l y , t h e p a t i e n t s were c l a s s i f i e d (Vezina and Sutton) i n GI: n=3 ( 0 ); G2: n. 5 ( 4 9 . ld); 63: n=3 ( 1 9 .
2 6 ) and G4: nz2 ( 8 ) . E i g h t p a t i e n t s (40. 4 3 ) were i n i t i a l l y t r e a t e d w i t h surgery. 7 o f them ( 3 Y . 4 6 ) w i t h a p e r s i s t e n t hyperprolactinemia r e q u i r e d Bromoc r i p t i n e (BEC) a f t e r surgery. I n 5 cases ( 4 Y . lo") 8EC c o n s t i t u t e d t h e primary treatment. b u t 1 y w i t h f a i l u r e t o 8EC therapy needed transsphenoidal adenomectomy. Follow-up was p o s s i b l e i n 11 p a t i e n t s . Among those who underwent surgery, 1 Y r ecovered gonadal f u n c t l o n spontaneously and 5 cases ( 3 ? , 2 6 ) r e q u i r e d complement a r y medical treatment. Among those t r e a t e d i n i t i a l l y w i t h BEC 1 $ recovered menses spontaneously. 1 9 needed progesterone therapy, 1 0 d i d n o t achieve normal PRL values a f t e r 9 m o f treatment, t h e adolescent who r e q u l r e d surgery had normal PRL l ev e l s w i t h o u t menses and thed'recovered gonadal function. I n conclusion: -Basal PRL l e v e l s seem t o be the most r e l e v a n t element i n h t e diagnosis o f prolactinomas.
-C l i n i c a l t r i a l s would suggest an increase i n tumoral growth v e l o c~t y i n males. -I n p e d i a t r i c p a t i e n t s . BEC appears as a useful resource f o r primary o r complementary treatment o f prolactinomas.
